Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.
Texas Children's Hospital, Baylor College of Medicine, Houston, Texas.
Diabetes Technol Ther. 2020 Sep;22(9):697-700. doi: 10.1089/dia.2019.0497. Epub 2020 Mar 10.
There are multiple information sources available to assist families in learning about rapidly advancing diabetes technologies as care options for their children. This study explored where and from whom families of young children with type 1 diabetes get information about diabetes technologies and the valence (positive vs. negative) of that information. Semi-structured interviews were conducted with parents (86% mothers) of 79 youth <8 years old with type 1 diabetes for ≥6 months, ([mean ± standard deviation] age 5.2 ± 1.5 years, diabetes duration 2.4 ± 1.3 years, 77% white, A1c 63 ± 10 mmol/mol [7.9 ± 0.9%], 66% pump-treated, 58% using continuous glucose monitors [CGMs]). Interviews were transcribed and underwent content analysis to derive central themes. Most parents reported learning about new technologies from three direct sources: diabetes care providers, people with diabetes, and caregivers of children with diabetes. Parents also cited three indirect sources of information: online forums, publications, and diabetes-specific conferences. Parents reported hearing primarily positive things about technologies. Families not using pump and/or CGM noted reluctance to use technology due to family-specific concerns (e.g., cost, child's unwillingness to wear device) rather than information from outside sources. In this subset of parents, many still expressed willingness to initiate use once family-specific concerns were resolved. Parents of young children received largely positive information about diabetes technologies, primarily from health care providers and others familiar with using devices personally or for their children. To maximize diabetes technology use in young children, it is incumbent upon providers to ensure families receive balanced realistic information about benefits and barriers.
有多种信息来源可以帮助家庭了解不断发展的糖尿病技术,作为他们孩子的护理选择。本研究探讨了年轻 1 型糖尿病儿童的家庭从何处以及从谁那里获得有关糖尿病技术的信息,以及这些信息的性质(正面还是负面)。对 79 名年龄<8 岁且患有 1 型糖尿病≥6 个月的儿童的父母(86%为母亲)进行了半结构化访谈,([均值±标准差]年龄 5.2±1.5 岁,糖尿病病程 2.4±1.3 年,77%为白人,A1c63±10mmol/mol[7.9±0.9%],66%接受胰岛素泵治疗,58%使用连续血糖监测仪[CGM])。访谈记录被转录,并进行内容分析以得出核心主题。大多数父母报告从三个直接来源了解新技术:糖尿病护理提供者、糖尿病患者和儿童糖尿病护理者。父母还提到了三个间接信息来源:在线论坛、出版物和专门针对糖尿病的会议。父母报告主要听到有关技术的积极信息。未使用胰岛素泵和/或 CGM 的家庭指出,由于家庭特定的问题(例如,成本、孩子不愿意佩戴设备)而不是来自外部来源的信息,他们不愿意使用技术。在这部分父母中,许多人仍然表示愿意在解决家庭特定问题后开始使用。年轻儿童的父母主要从医疗保健提供者和其他熟悉个人使用或为其孩子使用设备的人那里获得有关糖尿病技术的正面信息。为了最大限度地提高年轻儿童对糖尿病技术的使用,提供者有责任确保家庭获得有关益处和障碍的平衡现实信息。